Veeva Systems Acquires Crossix Solutions for $430 Million

Scipher Medicine Acquires CrossBridge to Add Real-time Patient Data and Analytics Platform

January 10, 2023

Data & Analytics

Scipher Medicine has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data management and analytics capabilities. The acquisition (closed; terms not disclosed) adds CrossBridge's SaaS value-based care platform to enable real-time mapping of patient molecular, clinical and claims data and to support Scipher's precision immunology offerings such as the PrismRA test.

TriNetX Acquires Advera Health Analytics

January 21, 2022

Data & Analytics

TriNetX has acquired Advera Health Analytics, the developer of the Evidex pharmacovigilance platform, to integrate Advera’s drug safety software and datasets into its real-world data network. The deal aims to give life sciences clients real-time safety signal detection, validation, and investigation capabilities by combining Evidex with TriNetX’s federated clinical datasets.

Fresenius Kabi Acquires Ivenix

March 31, 2022

Medical Devices

Ivenix, Inc. has entered into a definitive agreement to be acquired by Fresenius Kabi for an upfront payment of $240 million plus additional milestone payments. The deal brings Ivenix's next-generation infusion pump technology and software together with Fresenius Kabi's IV fluids and infusion therapy portfolio to create a comprehensive infusion offering and accelerate U.S. commercial expansion.

RLJ Equity Partners Acquires Virteva and Merges It Into Crossfuze

April 10, 2019

IT Services

RLJ Equity Partners acquired a majority interest in Virteva and will merge the Virteva team into Crossfuze to strengthen ServiceNow and managed services capabilities. The combined organization expands Crossfuze's global footprint, bringing additional ServiceNow consultants and widening its managed services offering to corporate and government customers.

Q² Solutions (IQVIA) Acquires Nexelis from Ampersand Capital Partners

January 10, 2022

Healthcare Services

Ampersand Capital Partners sold its portfolio company Nexelis to Q² Solutions, a wholly owned subsidiary of IQVIA, Inc. Nexelis, a Laval, Quebec–based provider of assay development and advanced clinical-trial laboratory testing with five operating sites in North America and Europe, will be integrated into IQVIA's global laboratory services to expand capabilities and capacity for vaccine, immunology and other drug-development testing.

V2X Acquires QinetiQ U.S. Intelligence Business

September 24, 2025

Aerospace & Defense

V2X, Inc. (NYSE: VVX) completed the acquisition of QinetiQ’s U.S. Intelligence business for approximately $24 million (net of estimated tax benefits). The deal brings roughly 70 intelligence, data engineering, and cyber professionals into V2X and expands the company's capabilities and access to critical national security programs.